GlassScriptPhysician profile
Augusto C Posadas
NPI 1124036371
$81,082.79
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55K · 2020: $11K · 2021: $8,820 · 2022: $5,943.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21,628.02 | 2019-2022 | |
| Genzyme Corporation | $16,361.51 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $12,065.09 | 2019-2022 | |
| Ucb, INC. | $7,621.85 | 2019-2022 | |
| Gilead Sciences, INC. | $7,473.60 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $4,781.02 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $4,126.40 | 2019 | |
| Amgen INC. | $1,624.92 | 2019-2022 | |
| Pfizer INC. | $942.24 | 2019-2022 | |
| Lilly USA, LLC | $667.52 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $545.64 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $493.64 | 2019-2021 | |
| Horizon Therapeutics Plc | $397.70 | 2019-2022 | |
| Janssen Biotech, INC. | $360.97 | 2019-2022 | |
| Radius Health, INC. | $308.37 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $287.48 | 2019-2021 | |
| Celgene Corporation | $198.98 | 2019 | |
| Mallinckrodt Hospital Products INC. | $179.46 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $150.57 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.91 | 2020-2022 | |
| Glaxosmithkline, LLC. | $85.30 | 2020-2022 | |
| Alexion Pharmaceuticals, INC. | $79.67 | 2019-2022 | |
| Pacira Therapeutics, INC. | $59.24 | 2019 | |
| Mallinckrodt Enterprises LLC | $57.76 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $38.73 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $35.19 | 2022 | |
| Ferring Pharmaceuticals INC. | $33.93 | 2020 | |
| Hikma Pharmaceuticals USA | $25.84 | 2019-2020 | |
| Aurinia Pharma U.S., INC. | $18.05 | 2021 | |
| Collegium Pharmaceutical, INC. | $15.23 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Augusto Posadas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.